Drug recall · September 4, 2019
Eptifibatide Injection recall
Why: Short Fill: fill volume was out of specification at 94 mL (specification: no less than 100 mL) and Failed Impurities/Degradation Specifications: Out of Specification (OOS) for known impurity, D-aspartic acid.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Eptifibatide Injection, 75 mg/100 mL (0.75 mg/mL), 100 mL Single-use Vial, For Intravenous Use Only, Rx Only, Manufactured by: Akorn Inc., Lake Forest, IL 60045, NDC 17478-903-90.
- Lots / codes
Lot #: 101107A, Exp. 10/19.
- Quantity
- 648 vials
- Company
- Akorn, Inc., Lake Forest, IL
- Distribution
- Nationwide in the U.S.
- Initiated
- August 6, 2019 · Voluntary: Firm initiated
- Classified
- August 23, 2019
- Reported
- September 4, 2019
- Ended
- July 28, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Eptifibatide
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.